Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana
Identifieur interne : 000809 ( Main/Exploration ); précédent : 000808; suivant : 000810Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana
Auteurs : Stacey Kallem [États-Unis] ; Lorna Renner [Ghana] ; Musie Ghebremichael [États-Unis] ; Elijah Paintsil [États-Unis]Source :
- AIDS and behavior [ 1090-7165 ] ; 2011.
Descripteurs français
- KwdFr :
- Adolescent, Agents antiVIH (usage thérapeutique), Aidants (psychologie), Caractéristiques familiales, Enfant, Femelle, Ghana (épidémiologie), Humains, Hôpitaux d'enseignement, Infections à VIH (diagnostic), Infections à VIH (traitement médicamenteux), Infections à VIH (épidémiologie), Mâle, Prévalence, Révélation de la vérité, Thérapie antirétrovirale hautement active, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Études transversales.
- MESH :
- diagnostic : Infections à VIH.
- psychologie : Aidants.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Agents antiVIH.
- épidémiologie : Ghana, Infections à VIH.
- Adolescent, Caractéristiques familiales, Enfant, Femelle, Humains, Hôpitaux d'enseignement, Mâle, Prévalence, Révélation de la vérité, Thérapie antirétrovirale hautement active, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Études transversales.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Adolescent, Anti-HIV Agents (therapeutic use), Antiretroviral Therapy, Highly Active, Caregivers (psychology), Child, Cross-Sectional Studies, Family Characteristics, Female, Ghana (epidemiology), HIV Infections (diagnosis), HIV Infections (drug therapy), HIV Infections (epidemiology), HIV-1, Hospitals, Teaching, Humans, Male, Prevalence, Truth Disclosure.
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- geographic , epidemiology : Ghana.
- diagnosis : HIV Infections.
- drug therapy : HIV Infections.
- epidemiology : HIV Infections.
- psychology : Caregivers.
- Adolescent, Antiretroviral Therapy, Highly Active, Child, Cross-Sectional Studies, Family Characteristics, Female, HIV-1, Hospitals, Teaching, Humans, Male, Prevalence, Truth Disclosure.
Abstract
With the advent of highly active antiretroviral therapy (HAART) HIV-infected children are surviving into adulthood. Despite, emerging evidence of the benefits of disclosure, when and how to disclose the diagnosis of HIV to children remain a clinical dilemma. We investigated the prevalence and determinants of HIV disclosure in a cross-sectional study of 71 caregiver-child dyads from the Pediatric HIV/AIDS Care Program at Korle-Bu Teaching Hospital (Accra, Ghana). The children were from 8 to 14 years with median age of 10.39 years. The prevalence of disclosure was 21%. Age (p<0.01), the level of education (p<0.01), deceased biologic father (p=0.02), administration of own HIV medications (p=0.02), and longer duration on HIV medication (p=0.02) were significantly associated with disclosure. The low prevalence of disclosure underscores the need for a systematic and a staged approach in disclosing HIV status to infected children in resource limited countries.
Url:
DOI: 10.1007/s10461-010-9741-9
PubMed: 20607381
PubMed Central: 2989337
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000246
- to stream Pmc, to step Curation: 000245
- to stream Pmc, to step Checkpoint: 000371
- to stream PubMed, to step Corpus: 000103
- to stream PubMed, to step Curation: 000103
- to stream PubMed, to step Checkpoint: 000103
- to stream Ncbi, to step Merge: 000371
- to stream Ncbi, to step Curation: 000371
- to stream Ncbi, to step Checkpoint: 000371
- to stream Main, to step Merge: 000810
- to stream Main, to step Curation: 000809
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana</title><author><name sortKey="Kallem, Stacey" sort="Kallem, Stacey" uniqKey="Kallem S" first="Stacey" last="Kallem">Stacey Kallem</name><affiliation wicri:level="2"><nlm:aff id="A1"> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven, CT</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name><affiliation wicri:level="3"><nlm:aff id="A2"> Department of Child Health, University of Ghana Medical School, Accra, Ghana</nlm:aff><country xml:lang="fr">Ghana</country><wicri:regionArea> Department of Child Health, University of Ghana Medical School, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Ghebremichael, Musie" sort="Ghebremichael, Musie" uniqKey="Ghebremichael M" first="Musie" last="Ghebremichael">Musie Ghebremichael</name><affiliation wicri:level="2"><nlm:aff id="A3"> Department of Biostatistics, Harvard University, Boston, MA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea> Department of Biostatistics, Harvard University, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Paintsil, Elijah" sort="Paintsil, Elijah" uniqKey="Paintsil E" first="Elijah" last="Paintsil">Elijah Paintsil</name><affiliation wicri:level="2"><nlm:aff id="A1"> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven, CT</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20607381</idno><idno type="pmc">2989337</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989337</idno><idno type="RBID">PMC:2989337</idno><idno type="doi">10.1007/s10461-010-9741-9</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">000246</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000246</idno><idno type="wicri:Area/Pmc/Curation">000245</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000245</idno><idno type="wicri:Area/Pmc/Checkpoint">000371</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000371</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">000103</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000103</idno><idno type="wicri:Area/PubMed/Curation">000103</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000103</idno><idno type="wicri:Area/PubMed/Checkpoint">000103</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000103</idno><idno type="wicri:Area/Ncbi/Merge">000371</idno><idno type="wicri:Area/Ncbi/Curation">000371</idno><idno type="wicri:Area/Ncbi/Checkpoint">000371</idno><idno type="wicri:doubleKey">1090-7165:2011:Kallem S:prevalence:and:pattern</idno><idno type="wicri:Area/Main/Merge">000810</idno><idno type="wicri:Area/Main/Curation">000809</idno><idno type="wicri:Area/Main/Exploration">000809</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana</title><author><name sortKey="Kallem, Stacey" sort="Kallem, Stacey" uniqKey="Kallem S" first="Stacey" last="Kallem">Stacey Kallem</name><affiliation wicri:level="2"><nlm:aff id="A1"> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven, CT</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name><affiliation wicri:level="3"><nlm:aff id="A2"> Department of Child Health, University of Ghana Medical School, Accra, Ghana</nlm:aff><country xml:lang="fr">Ghana</country><wicri:regionArea> Department of Child Health, University of Ghana Medical School, Accra</wicri:regionArea><placeName><settlement type="city">Accra</settlement><region nuts="2">Région du Grand Accra</region></placeName></affiliation></author><author><name sortKey="Ghebremichael, Musie" sort="Ghebremichael, Musie" uniqKey="Ghebremichael M" first="Musie" last="Ghebremichael">Musie Ghebremichael</name><affiliation wicri:level="2"><nlm:aff id="A3"> Department of Biostatistics, Harvard University, Boston, MA</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea> Department of Biostatistics, Harvard University, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Paintsil, Elijah" sort="Paintsil, Elijah" uniqKey="Paintsil E" first="Elijah" last="Paintsil">Elijah Paintsil</name><affiliation wicri:level="2"><nlm:aff id="A1"> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven, CT</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea> Department of Pediatrics and Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author></analytic><series><title level="j">AIDS and behavior</title><idno type="ISSN">1090-7165</idno><idno type="eISSN">1573-3254</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Anti-HIV Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active</term><term>Caregivers (psychology)</term><term>Child</term><term>Cross-Sectional Studies</term><term>Family Characteristics</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Infections (diagnosis)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>HIV-1</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Prevalence</term><term>Truth Disclosure</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Agents antiVIH (usage thérapeutique)</term><term>Aidants (psychologie)</term><term>Caractéristiques familiales</term><term>Enfant</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Hôpitaux d'enseignement</term><term>Infections à VIH (diagnostic)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (épidémiologie)</term><term>Mâle</term><term>Prévalence</term><term>Révélation de la vérité</term><term>Thérapie antirétrovirale hautement active</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Aidants</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Caregivers</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Antiretroviral Therapy, Highly Active</term><term>Child</term><term>Cross-Sectional Studies</term><term>Family Characteristics</term><term>Female</term><term>HIV-1</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Prevalence</term><term>Truth Disclosure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Caractéristiques familiales</term><term>Enfant</term><term>Femelle</term><term>Humains</term><term>Hôpitaux d'enseignement</term><term>Mâle</term><term>Prévalence</term><term>Révélation de la vérité</term><term>Thérapie antirétrovirale hautement active</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">With the advent of highly active antiretroviral therapy (HAART) HIV-infected children are surviving into adulthood. Despite, emerging evidence of the benefits of disclosure, when and how to disclose the diagnosis of HIV to children remain a clinical dilemma. We investigated the prevalence and determinants of HIV disclosure in a cross-sectional study of 71 caregiver-child dyads from the Pediatric HIV/AIDS Care Program at Korle-Bu Teaching Hospital (Accra, Ghana). The children were from 8 to 14 years with median age of 10.39 years. The prevalence of disclosure was 21%. Age (p<0.01), the level of education (p<0.01), deceased biologic father (p=0.02), administration of own HIV medications (p=0.02), and longer duration on HIV medication (p=0.02) were significantly associated with disclosure. The low prevalence of disclosure underscores the need for a systematic and a staged approach in disclosing HIV status to infected children in resource limited countries.</p></div></front></TEI><affiliations><list><country><li>Ghana</li><li>États-Unis</li></country><region><li>Connecticut</li><li>Massachusetts</li><li>Région du Grand Accra</li></region><settlement><li>Accra</li></settlement></list><tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Kallem, Stacey" sort="Kallem, Stacey" uniqKey="Kallem S" first="Stacey" last="Kallem">Stacey Kallem</name></region><name sortKey="Ghebremichael, Musie" sort="Ghebremichael, Musie" uniqKey="Ghebremichael M" first="Musie" last="Ghebremichael">Musie Ghebremichael</name><name sortKey="Paintsil, Elijah" sort="Paintsil, Elijah" uniqKey="Paintsil E" first="Elijah" last="Paintsil">Elijah Paintsil</name></country><country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000809 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000809 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:2989337
|texte= Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20607381" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |